Showing results (231-240 of 976) with videos related to

Sort By:
Pageof 98
NPJ Breast Cancer|July 9, 2026
Routine germline genetic testing in 3552 unselected NHS breast cancer patients: evidence informing testing criteria and implementation of a 'BRCA-DIRECT' mainstreaming pathwayBethany Torr, Lea Mansour, Caitlin T Fierheller, et al.
NPJ Breast Cancer|June 22, 2026
Effects of breast cancer risk factors on the tumor microenvironment: a morphological deep-learning analysis of three prospective cohortsClara Bodelon, Mohamed Amgad, James M Hodge, et al.
NPJ Breast Cancer|June 27, 2026
ACSS2-mediated metabolic-epigenetic crosstalk drives Fulvestrant resistance and represents a novel therapeutic targetAyça N Mogol, Jin Young Yoo, Alicia Arredondo Eve, et al.
NPJ Breast Cancer|June 30, 2026
Multi-omics analysis in suspected hereditary breast and ovarian cancer cases reveals novel candidate susceptibility factorsB Aldrige Allister, Winfried Hofmann, Jonathan L Lühmann, et al.
NPJ Breast Cancer|July 6, 2026
Impact of neoadjuvant chemotherapy on local breast microbiota and macrophages in ER-positive breast cancer with links to treatment responseSabine Dieleman, Carlijn Bruggeling, Phuc Dat Le, et al.
NPJ Breast Cancer|June 25, 2019
SETER/PR: a robust 18-gene predictor for sensitivity to endocrine therapy for metastatic breast cancerBruno V Sinn, Chunxiao Fu, Rosanna Lau, et al.
NPJ Breast Cancer|May 8, 2023
Inhibition of CXorf56 promotes PARP inhibitor-induced cytotoxicity in triple-negative breast cancerYing Zhu, Zhixian Liu, Liang Gui, et al.
NPJ Breast Cancer|February 2, 2018
Characterization of bone only metastasis patients with respect to tumor subtypesAmanda Parkes, Katherine Clifton, Aydah Al-Awadhi, et al.
NPJ Breast Cancer|May 16, 2020
Pitfalls in assessing stromal tumor infiltrating lymphocytes (sTILs) in breast cancerZuzana Kos, Elvire Roblin, Rim S Kim, et al.
NPJ Breast Cancer|August 4, 2022
The association between adiposity and anti-proliferative response to neoadjuvant endocrine therapy with letrozole in post-menopausal patients with estrogen receptor positive breast cancerEdoardo Isnaldi, François Richard, Maxim De Schepper, et al.
Pageof 98